A Double Blind Study for the Treatment of Acute Ulcerative Colitis
NCT00350415
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
772
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Mesalamine
Sponsor
Warner Chilcott